Clinical Scorecard: Incidence of Renal Arterial Pseudoaneurysm Following Robotic-Assisted Partial Nephrectomy: Insights from a Single-Center Study

At a Glance

Key Highlights

• RAP is a rare but serious complication after RaPN with an incidence of 2.6% in the studied cohort.
• Clinical signs of RAP include gross hematuria, flank pain, and anemia, usually presenting around 9.5 days postoperatively.
• Transarterial embolization is an effective treatment for hemodynamically unstable RAP patients.

Guideline-Based Recommendations

Diagnosis

• Suspect RAP in patients with hematuria, flank pain, or anemia after RaPN.
• Confirm diagnosis with computed tomography (CT) angiography when clinical signs are present.

Management

• Perform transarterial embolization for patients with clinically significant RAP requiring intervention.
• Conservative management may be considered for select patients with RAP who are hemodynamically stable.

Monitoring & Follow-up

• Routine outpatient follow-up 10–14 days after discharge to assess recovery and pathology.
• Follow-up imaging with ultrasound and CT alternated every 3 months during the first postoperative year for asymptomatic patients.
• CT renal angiography reserved for symptomatic patients suggestive of RAP.

Risks

• RAP risk factors remain inconclusive regarding tumor complexity scores (RENAL and PADUA).
• Use of antiplatelet or anticoagulant therapy may be present but is not definitively linked to RAP occurrence.

Patient & Prescribing Data

Patients undergoing robotic-assisted partial nephrectomy for renal tumors

Most RAP cases require embolization; conservative treatment is possible in select cases. Early recognition and intervention are critical.

Clinical Best Practices

• Use RENAL nephrometry and PADUA scores to assess tumor complexity preoperatively, although their predictive value for RAP is uncertain.
• Ensure meticulous surgical technique including vascular control, renorrhaphy, and use of hemostatic agents during RaPN.
• Maintain vigilant postoperative monitoring for signs of RAP to enable timely diagnosis and management.
• Coordinate multidisciplinary care involving urologists and interventional radiologists for optimal RAP treatment.

References

• Epidemiology of renal cell carcinoma
• RENAL nephrometry score description
• PADUA score for renal tumor complexity
• Management of renal artery pseudoaneurysm